References:
  1. Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., Forouzanfar, M. H., Naghavi, M., Mensah, G. A., Ezzati, M., & Murray, C. J. L. (2014). Worldwide epidemiology of Atrial Fibrillation. Circulation ,129 (8), 837–847.https://doi.org/10.1161/circulationaha.113.005119
  2. Poli, D., & Antonucci, E. (2015). Epidemiology, diagnosis, and management of atrial fibrillation in women. International Journal of Women’s Health , 605.https://doi.org/10.2147/ijwh.s45925
  3. Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., Elkind, M. S. V., Evenson, K. R., Eze-Nliam, C., Ferguson, J. F., Generoso, G., Ho, J. E., Kalani, R., Khan, S. S., Kissela, B. M., … Martin, S. S. (2022). Heart disease and stroke statistics—2022 update: A report from the American Heart Association. Circulation , 145 (8).https://doi.org/10.1161/cir.0000000000001052
  4. Dagres, N., Nieuwlaat, R., Vardas, P. E., Andresen, D., Lévy, S., Cobbe, S., Kremastinos, D. T., Breithardt, G., Cokkinos, D. V., & Crijns, H. J. G. M. (2007). Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe. Journal of the American College of Cardiology , 49 (5), 572–577.https://doi.org/10.1016/j.jacc.2006.10.047
  5. Volgman, A. S., Benjamin, E. J., Curtis, A. B., Fang, M. C., Lindley, K. J., Naccarelli, G. V., Pepine, C. J., Quesada, O., Vaseghi, M., Waldo, A. L., Wenger, N. K., & Russo, A. M. (2020). Women and atrial fibrillation. Journal of Cardiovascular Electrophysiology ,32 (10), 2793–2807.https://doi.org/10.1111/jce.14838
  6. Friberg, J., Scharling, H., Gadsbøll, N., Truelsen, T., & Jensen, G. B. (2004). Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (the Copenhagen City Heart Study). The American Journal of Cardiology ,94 (7), 889–894.https://doi.org/10.1016/j.amjcard.2004.06.023
  7. Olesen, J. B., Lip, G. Y., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., & Torp-Pedersen, C. (2011). Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study.BMJ , 342 (jan31 1), d124–d124.https://doi.org/10.1136/bmj.d124
  8. Fang, M. C., Singer, D. E., Chang, Y., Hylek, E. M., Henault, L. E., Jensvold, N. G., & Go, A. S. (2005). Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation.Circulation , 112 (12), 1687–1691.https://doi.org/10.1161/circulationaha.105.553438
  9. Westerman, S., & Wenger, N. (2019). Gender differences in atrial fibrillation: A review of Epidemiology, management, and outcomes.Current Cardiology Reviews , 15 (2), 136–144.https://doi.org/10.2174/1573403x15666181205110624
  10. Piccini, J. P., Simon, D. J. N., Steinberg, B. A., Thomas, L., Allen, L. A., Fonarow, G. C., Gersh, B., Hylek, E., Kowey, P. R., Reiffel, J. A., Naccarelli, G. V., Chan, P. S., Spertus, J. A., & Peterson, E. D. (2016). Differences in clinical and functional outcomes of atrial fibrillation in women and men. JAMA Cardiology , 1 (3), 282.https://doi.org/10.1001/jamacardio.2016.0529
  11. Rienstra, M., Van Veldhuisen, D. J., Hagens, V. E., Ranchor, A. V., Veeger, N. J. G. M., Crijns, H. J. G. M., & Van Gelder, I. C. (2005).Gender-related differences in rhythm control treatment in persistent atrial fibrillation. Journal of the American College of Cardiology , 46 (7), 1298–1306.https://doi.org/10.1016/j.jacc.2005.05.078
  12. Forleo, G. B., Tondo, C., De Luca, L., Russo, A. D., Casella, M., De Sanctis, V., Clementi, F., Fagundes, R. L., Leo, R., Romeo, F., & Mantica, M. (2007). Gender-related differences in catheter ablation of atrial fibrillation. EP Europace , 9 (8), 613–620.https://doi.org/10.1093/europace/eum144
  13. Avgil Tsadok, M., Gagnon, J., Joza, J., Behlouli, H., Verma, A., Essebag, V., & Pilote, L. (2015). Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation.Heart Rhythm , 12 (9), 1979–1986.https://doi.org/10.1016/j.hrthm.2015.06.029
  14. Takigawa, M., Kuwahara, T., Takahashi, A., Watari, Y., Okubo, K., Takahashi, Y., Takagi, K., Kuroda, S., Osaka, Y., Kawaguchi, N., Yamao, K., Nakashima, E., Sugiyama, T., Akiyama, D., Kamiishi, T., Kimura, S., Hikita, H., Hirao, K., & Isobe, M. (2013). Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. International Journal of Cardiology , 168 (3), 1984–1991.https://doi.org/10.1016/j.ijcard.2012.12.101
  15. Kaiser, D. W., Fan, J., Schmitt, S., Than, C. T., Ullal, A. J., Piccini, J. P., Heidenreich, P. A., & Turakhia, M. P. (2016). Gender differences in clinical outcomes after catheter ablation of atrial fibrillation. JACC: Clinical Electrophysiology , 2 (6), 703–710.https://doi.org/10.1016/j.jacep.2016.04.014
  16. Santangeli, P., Di Biase, L, Pelargonio, G, & Natale, A. (2010). Outcome of invasive electrophysiological procedures and gender: Are males and females the same? Journal of Cardiovascular Electrophysiology , 22 (5), 605–612.https://doi.org/10.1111/j.1540-8167.2010.01920.x
  17. Schnabel, R. B., Pecen, L., Ojeda, F. M., Lucerna, M., Rzayeva, N., Blankenberg, S., Darius, H., Kotecha, D., Caterina, R. D., & Kirchhof, P. (2017). Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation. Heart , 103 (13), 1024–1030.https://doi.org/10.1136/heartjnl-2016-310406
  18. Cheng, X., Hu, Q., Gao, L., Liu, J., Qin, S., & Zhang, D. (2019). Sex-related differences in catheter ablation of atrial fibrillation: A systematic review and meta-analysis. EP Europace ,21 (10), 1509–1518.https://doi.org/10.1093/europace/euz179
  19. Park, Y. J., Park, J.-W., Yu, H. T., Kim, T.-H., Uhm, J.-S., Joung, B., Lee, M.-H., & Pak, H.-N. (2022). Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs. Heart .https://doi.org/10.1136/heartjnl-2021-320601
  20. Bunch TJ, May HT, Bair TL, et al. Five-year outcomes of catheter ablation in patients with atrial fibrillation: is atrial fibrillation a curable disease? J Am Coll Cardiol. 2011;57(2):137-146. doi:10.1016/j.jacc.2010.05.061.
  21. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014 Feb 5;311(5):498-506. doi: 10.1001/jama.2014.3. Erratum in: JAMA. 2014 Nov 5;312(17):1805. PMID: 24496537.
  22. Chelu MG, King JB, Kholmovski EG, Ma J, Gal P, Marashly Q, AlJuaid MA, Kaur G, Silver MA, Johnson KA, Suksaranjit P, Wilson BD, Han FT, Elvan A, Marrouche NF. Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up Data. J Am Heart Assoc. 2018 Dec 4;7(23):e006313. doi: 10.1161/JAHA.117.006313. PMID: 30511895; PMCID: PMC6405558.
  23. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G; EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29. PMID: 32865375.
  24. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra PG, Dubuc M, Reddy V, Nelson L, Holcomb RG, Lehmann JW, Ruskin JN; STOP AF Cryoablation Investigators. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013 Apr 23;61(16):1713-23. doi: 10.1016/j.jacc.2012.11.064. Epub 2013 Mar 21. PMID: 23500312.
  25. Zhao Y, Krupadev V, Dagher L, Mahnkopf C, Sohns C, Sehner S, Suling A, Sanders P, Boersma L, Schunkert H, Wegscheider K, Brachmann J, Marrouche NF. Pharmacological rhythm versus rate control in patients with atrial fibrillation and heart failure: the CASTLE-AF trial. J Interv Card Electrophysiol. 2021 Sep;61(3):609-615. doi: 10.1007/s10840-020-00856-1. Epub 2020 Sep 4. PMID: 32888121.
  26. Mohanty S, Trivedi C, Gianni C, Natale A. Gender specific considerations in atrial fibrillation treatment: a review.Expert OpinPharmacother. 2018;19:365‐374.7.